Estimates Revisions Regeneron Pharmaceuticals, Inc. Sao Paulo
Stocks
REGN34
BRREGNBDR005
Pharmaceuticals
|
Delayed
Sao Paulo
09:48:44 05/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 60.40 BRL | -5.30% |
|
-8.41% | -14.75% |
| 02/10 | Jefferies Raises Regeneron Pharmaceuticals Price Target to $930 From $870, Maintains Buy Rating | MT |
| 02/10 | Major drugmakers turn to China for licensing deals | RE |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
Regeneron Pharmaceuticals, Inc.(REGN)
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Data source:
Regeneron Pharmaceuticals, Inc.(REGN)
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
Data source:
Regeneron Pharmaceuticals, Inc.(REGN)
EBIT
Dividend / Share (DPS)
Data source:
Regeneron Pharmaceuticals, Inc.(REGN)
Cash or Net Debt
- Stock Market
- Stocks
- REGN Stock
- REGN34 Stock
- Consensus Regeneron Pharmaceuticals, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
